These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 33998747)

  • 1. Voiding dysfunctions in patients with non-Hunner's ulcer interstitial cystitis/bladder pain syndrome do not affect long-term treatment outcome.
    Yu WR; Chang WC; Kuo HC
    Int J Clin Pract; 2021 Sep; 75(9):e14372. PubMed ID: 33998747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeated intravesical onabotulinumtoxinA injections are effective in treatment of refractory interstitial cystitis/bladder pain syndrome.
    Kuo HC
    Int J Clin Pract; 2013 May; 67(5):427-34. PubMed ID: 23574103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravesical botulinum toxin a injections do not benefit patients with ulcer type interstitial cystitis.
    Lee CL; Kuo HC
    Pain Physician; 2013; 16(2):109-16. PubMed ID: 23511677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cystoscopic hydrodistention characteristics provide clinical and long-term prognostic features of interstitial cystitis after treatment.
    Yu WR; Jhang JF; Ho HC; Jiang YH; Lee CL; Hsu YH; Kuo HC
    Sci Rep; 2021 Jan; 11(1):455. PubMed ID: 33432045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Videourodynamic characteristics of interstitial cystitis/bladder pain syndrome-The role of bladder outlet dysfunction in the pathophysiology.
    Kuo YC; Kuo HC
    Neurourol Urodyn; 2018 Aug; 37(6):1971-1977. PubMed ID: 29504632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pelvic Floor Myofascial Pain Might Influence Treatment Outcome of Interstitial Cystitis/Bladder Pain Syndrome: A Prospective Study.
    Yu WR; Chuang FC; Chang WC; Kuo HC
    Pain Physician; 2022 Nov; 25(8):E1315-E1322. PubMed ID: 36375205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does repeated hydrodistension with transurethral fulguration for interstitial cystitis with Hunner's lesion cause bladder contraction?
    Tomoe H; Yamashita K
    Arab J Urol; 2019 Mar; 17(1):77-81. PubMed ID: 31258947
    [No Abstract]   [Full Text] [Related]  

  • 8. Usefulness of Urinary Biomarkers for Assessing Bladder Condition and Histopathology in Patients with Interstitial Cystitis/Bladder Pain Syndrome.
    Jiang YH; Jhang JF; Hsu YH; Kuo HC
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anxiety severity does not influence treatment outcomes in patients with interstitial cystitis/bladder pain syndrome.
    Yu WR; Peng TC; Yeh HL; Kuo HC
    Neurourol Urodyn; 2019 Aug; 38(6):1602-1610. PubMed ID: 31059599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive Factors for a Satisfactory Treatment Outcome with Intravesical Botulinum Toxin A Injection in Patients with Interstitial Cystitis/Bladder Pain Syndrome.
    Wang HJ; Yu WR; Ong HL; Kuo HC
    Toxins (Basel); 2019 Nov; 11(11):. PubMed ID: 31752328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. O'Leary-Sant Symptom Index Predicts the Treatment Outcome for OnabotulinumtoxinA Injections for Refractory Interstitial Cystitis/Bladder Pain Syndrome.
    Kuo YC; Kuo HC
    Toxins (Basel); 2015 Jul; 7(8):2860-71. PubMed ID: 26264022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pain reduction realized with extracorporeal shock wave therapy for the treatment of symptoms associated with interstitial cystitis/bladder pain syndrome-A prospective, multicenter, randomized, double-blind, placebo-controlled study.
    Chuang YC; Meng E; Chancellor M; Kuo HC
    Neurourol Urodyn; 2020 Jun; 39(5):1505-1514. PubMed ID: 32394478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome and symptom improvement in patients with interstitial cystitis/bladder pain syndrome with or without regular follow-up and treatment.
    Yeh HL; Jhang JF; Kuo YC; Kuo HC
    Neurourol Urodyn; 2019 Sep; 38(7):1985-1993. PubMed ID: 31310370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical presentation, videourodynamic characteristics, and treatment outcome in men with interstitial cystitis-like lower urinary tract symptoms.
    Yu WR; Chang WC; Kuo HC
    Int Urol Nephrol; 2022 Sep; 54(9):2157-2165. PubMed ID: 35804206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of efficacy and safety between bladder body and trigonal intravesical onabotulinumtoxina injection in the treatment of interstitial cystitis refractory to conventional treatment-A prospective, randomized, clinical trial.
    Jiang YH; Jhang JF; Lee CL; Kuo HC
    Neurourol Urodyn; 2018 Apr; 37(4):1467-1473. PubMed ID: 29331031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Difference in electron microscopic findings among interstitial cystitis/bladder pain syndrome with distinct clinical and cystoscopic characteristics.
    Lee YK; Jhang JF; Jiang YH; Hsu YH; Ho HC; Kuo HC
    Sci Rep; 2021 Aug; 11(1):17258. PubMed ID: 34446784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of augmentation ileocystoplasty combined with supratrigonal cystectomy for the treatment of refractory bladder pain syndrome/interstitial cystitis with Hunner's lesion.
    Kim HJ; Lee JS; Cho WJ; Lee HS; Lee HN; You HW; Jung W; Lee KS
    Int J Urol; 2014 Apr; 21 Suppl 1():69-73. PubMed ID: 24807503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravesical injections of platelet-rich plasma is effective and safe in treatment of interstitial cystitis refractory to conventional treatment-A prospective clinical trial.
    Jhang JF; Lin TY; Kuo HC
    Neurourol Urodyn; 2019 Feb; 38(2):703-709. PubMed ID: 30576011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased urothelial cytoskeleton and cell proliferation protein expression suggest interstitial cystitis/bladder pain syndrome patients with Hunner's lesion and grade 3 glomerulation might be different from other types of patients.
    Jhang JF; Jiang YH; Hsu YH; Ho HC; Kuo HC
    Int J Urol; 2021 Aug; 28(8):823-830. PubMed ID: 33966299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeated intravesical injections of platelet-rich plasma are effective in the treatment of interstitial cystitis: a case control pilot study.
    Jhang JF; Wu SY; Lin TY; Kuo HC
    Low Urin Tract Symptoms; 2019 Apr; 11(2):O42-O47. PubMed ID: 29265766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.